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Most isolates of non-tuberculous mycobacteria (NTM) 
are either laboratory contaminants or human saprophytic 
microorganisms without clinical significance. However, 
NTM are potentially pathogenic, especially in patients 
with severe immunosuppression. 
First described in 1965 [I], Mycobacterium simiae is 
an NTM whlch can cause animal and human disease 
[2]. We report, to our knowledge, the eleventh docu- 
mented case of dmeminated infection due to M.  simiae 
in an AIDS patient. 
CASEREPORT 
A 48-year-old HIV-positive male was admitted with a 
4-week history of weight loss and fever. He had traveled 
to Mexico, the Dominican Republic and Zimbabwe 
during the last few years. On admission, he had a CD4 
count of 20 cells/pL. A thorough work-up (including 
chest X-ray and cranial and abdominal CT scans) failed 
to demonstrate an etiologic agent during the first 
hospital admission, and the patient was sent home with 
two antiretroviral drugs, isoniazid, rifampin, pyrazina- 
mide, ethambutol, clarithromycin and co-trimoxazole. 
M. simiae grew in a blood culture and a sputum culture 
after 32-45 days of incubation. The patient did not 
comply with treatment and was r e a h t t e d  for the 
evaluation of irregular fevers on two occasions. Finally, 
6 months later, he developed bilateral lung infiltrates 
and paratracheal lymphadenopathy. Again, a blood and 
two sputum cultures grew M. simiae. The patient rehsed 
all treatment, except for Prteumocystis carinii prophylaxis, 
and died 1 month later. 
Specimens were processed at our mycobacterial 
laboratory, decontaminated with 2% NaOH and 
inoculated in appropriate media (Lowenstein-Jensen 
and Coletsos); an auramine-rhodamine smear was 
also made. Blood cultures (BACTEC 9240, Becton 
Dickmson, Cockeysville, Maryland, USA) were pro- 
cessed using a lysis-centrifugation procedure developed 
in-house. Briefly, blood cultures were processed using 
negative aerobic bottles for other blood pathogens: we 
added 5mL of Middlebrook 7H9 to the vials and 
reincubated for 7 days. At this time, 10 mL of the blood 
broth culture was transferred into a conical tube with 
0.5 mL of sodium deoxycholate (0.1 g/mL) as lytic 
agent, and the samples were then centrifuged at 3800 g 
for 15 min. An aliquot of the leukocyte layer was taken 
for inoculation into Lowenstein-Jensen and Coletsos 
media and for smear preparation for auramine-rhoda- 
mine staining [3]. 
Identification of M.  simiae was based on the pre- 
sence of small, smooth, photochromogenic colonies 
22-60 days later (median time: 41 days). The isolates 
gave negative results with a chemiluminescent DNA 
probe specific for M .  aoium complex (MAC), M. 
tuberculosis and M.  kansasii (Accu-Probe, Gen-Probe, 
San Diego, California, USA), and positive results with 
the urease test, the niacin test and the heat-stable 
catalase test. M.  simiae was confirmed using gas-liquid 
chromatography (GLC) and PCR restriction pattern 
analysis (PRA) by a mycobacteriology reference labora- 
tory [4,5]. The isolates were resistant ‘in vitro’ to 
isoniazid, rifampin, streptomycin and ethambutol, 
and sensitive to ethionamide. The ratio of specimens 
received to positive specimens over a 6-month period 
was: sputa 4/3, blood 4/2 and urine 3/0. 
M. simiae was originally isolated fiom a group of 
Macacus rhesus monkeys in 1965 [l]. The organism has 
subsequently been recovered from tap water and soil 
[6,7], and also as a saprophytic microorganism or 
pathogen from monkeys [1,2]. M .  simiae is an un- 
common but well-known human colonizer, particularly 
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in specimens obtained from the respiratory tract and 
stools [8-111. Chronic lung disease attributable to M.  
sinziae has been reported both from patients with 
underlying pulmonary diseases and from immuno- 
compromised patients [9,11]. Disseminated infection is 
very uncommon. To our knowledge, only one case has 
been reported in non-HIV-infected patients [12]. Our 
case is the eleventh reported case with documented 
dissemination in AIDS [6,13-181 (Table 1). All the 
patients were male (median age of 38 years) with well- 
advanced AIDS (median CD4 of 45). Two cases involved 
co-infection with MAC, an uncommon characteristic 
of severe mycobacterial infections [13,16]. To our 
surprise, five (including ours) of the 11 cases reported 
a history of travel or residency in Africa [6,16-181. Our 
review of the literature shows that lung involvement 
occurred in seven patients, while extrathoracic involve- 
ment occurred in nine patients. In those cases that 
describe patient outcome, only two cures were reported 
in spite of subsequent antimycobacterial therapy [17,18]. 
Biochemically, M. simiae produces positive results 
with the niacin test, the heat-stable catalase test, the 
tellurite reduction, the urease test and the pyrazina- 
midase test, whereas the nitrate reduction, Tween-80 
hydrolysis, arylsulfatase test and phosphatase test are 
negative [ 191. Laboratory diagnosis requires a high 
degree of suspicion, as some isolates are not always 
photochromogenic. Morphologically, colonies may be 
indistinguishable for MAC and, like M.  tuberculosis, are 
niacin and heat-stable catalase positive. However, it is 
possible to differentiate them using a mycolic acids 
profile (GLC), or genetic structure (PRA). Adequate 
identification of M.  simiae is also particularly important, 
since most isolates are highly resistant in vitro to the 
majority of antimicrobial drugs commonly used for the 
treatment of M. tuberculosis and MAC infections, while 
ethionamide, clofazimine, cycloserine and amikacin 
show activity against this mycobacterium [20]. Never- 
theless, up to the present time, there is no clear 
correlation between the in vitro and in vivo efficacy of 
drugs against M.  simiae. A representative example was 
reported by Koeck et al [17], where clarithromycin in 
combination with ribafutin was used in spite of 
relatively high minimal inhibitory concentrations for 
both antimicrobial drugs (16 mg/L and 8 mg/L, respec- 
tively). 
In summary, M. simiae is a microorganism that is 
potentially responsible for disseminated disease in AIDS 
patients. Its prompt diagnosis and clinical recognition 
would involve changes in therapeutic management and 
outcome for the infected patients. 
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